Seenu Hariprasad to Vitreous Body
This is a "connection" page, showing publications Seenu Hariprasad has written about Vitreous Body.
Connection Strength
3.742
-
Reassessment of Scleral Depression in the Clinical Setting. Ophthalmology. 2015 Nov; 122(11):2360-1.
Score: 0.521
-
Surgical management of symptomatic vitreous floaters. Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec; 45(6):1-3.
Score: 0.500
-
Ocriplasmin: nonsurgical option for VMA and macular hole, but with potential barriers to practical use. Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr; 44(2):113-6; discussion p.113.
Score: 0.446
-
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol. 2006 Feb; 124(2):178-82.
Score: 0.273
-
Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J Cataract Refract Surg. 2005 Nov; 31(11):2142-6.
Score: 0.268
-
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol. 2005 Jan; 123(1):39-44.
Score: 0.253
-
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004 Jan; 122(1):42-7.
Score: 0.236
-
Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Trans Am Ophthalmol Soc. 2004; 102:149-55; discussion 155-7.
Score: 0.236
-
Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003 Mar; 121(3):345-50.
Score: 0.223
-
Vitreous penetration of orally administered gatifloxacin in humans. Trans Am Ophthalmol Soc. 2002; 100:153-9.
Score: 0.206
-
Endoscopy remains a valuable tool for vitreoretinal surgery. Ophthalmic Surg Lasers Imaging Retina. 2015 Jun; 46(6):606-8.
Score: 0.130
-
Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole. J Ocul Pharmacol Ther. 2008 Apr; 24(2):245-8.
Score: 0.079
-
Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008 Jan; 126(1):18-22.
Score: 0.078
-
Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection. Am J Ophthalmol. 2006 Jan; 141(1):200-1.
Score: 0.068
-
Rapid pathogen identification and antimicrobial susceptibility testing in in vitro endophthalmitis with matrix assisted laser desorption-ionization Time-of-Flight Mass Spectrometry and VITEK 2 without prior culture. PLoS One. 2019; 14(12):e0227071.
Score: 0.045
-
Intravitreal Injections: Minimizing the Risk and Maximizing Comfort. Ophthalmic Surg Lasers Imaging Retina. 2019 12 01; 51(1):5-8.
Score: 0.044
-
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012 Oct; 119(10):2125-32.
Score: 0.027
-
Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm. 2011 Feb; 19(1):32-8.
Score: 0.024
-
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology. 2009 Nov; 116(11):2141-8.e1.
Score: 0.022
-
Short-term intraocular pressure trends after intravitreal triamcinolone injection. Am J Ophthalmol. 2007 Feb; 143(2):365-7.
Score: 0.018
-
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005 Jan; 139(1):135-40.
Score: 0.016
-
Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol. 2004 Nov; 122(11):1687-92.
Score: 0.016
-
Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc. 2003; 101:183-9; discussion 189.
Score: 0.014